Opioid Prescribing and Polypharmacy in Children with Chronic Musculoskeletal Pain

OBJECTIVE Thirty percent of adults with fibromyalgia receive an opioid, but the prevalence of opioid prescribing in pediatric chronic musculoskeletal pain is unknown. The aims of this study were to determine the prevalence of and factors associated with opioid exposure and polypharmacy among children with chronic musculoskeletal pain. METHODS In this retrospective cohort study using health care claims data from 2000 to 2013, the index date was the first ICD-9 code 729.1. Included subjects were ≥ 2 and < 18 years old at the index date with two or more codes within 12 months and 18 months of continuous enrollment. Subjects with burns, sickle cell disease, or malignancy were excluded. Opioid exposure was defined as one or more prescriptions within six months before or any time after the index date. Polypharmacy was considered minor (2-4 medications) or major (≥5 medications). RESULTS Of 25,321 included subjects, 20% received an opioid and 26% experienced minor polypharmacy. Opioid exposure was associated with female sex (odds ratio [OR] = 1.27, P < 0.01), Caucasian race (OR = 1.27, P < 0.01), hospitalization (OR = 1.20, P < 0.01), and visit with anesthesiology (OR = 1.97, P < 0.01) or orthopedics (OR = 1.09, P < 0.05). Mental health codes were associated with decreased odds of opioid exposure (all P < 0.05). Children seen by a chiropractor or physiatrist had a reduced odds of receipt of an opioid (OR = 0.42 and 0.84, respectively, both P < 0.01). CONCLUSIONS Twenty percent of children with chronic musculoskeletal pain received an opioid. Twenty-six percent experienced polypharmacy, with the majority receiving 2-4 medications. Increased availability of psychological and nonpharmacologic services are potential strategies to reduce opioid exposure.

[1]  Thomas R Frieden,et al.  Ten Steps the Federal Government Should Take Now to Reverse the Opioid Addiction Epidemic. , 2017, JAMA.

[2]  Jill O Jin Risks of Codeine and Tramadol in Children. , 2017, JAMA.

[3]  Gillian E. Caughey,et al.  What is polypharmacy? A systematic review of definitions , 2017, BMC Geriatrics.

[4]  D. Kelley,et al.  Medicaid prior authorization and opioid medication abuse and overdose. , 2017, The American journal of managed care.

[5]  Gary A. Smith,et al.  Prescription Opioid Exposures Among Children and Adolescents in the United States: 2000–2015 , 2017, Pediatrics.

[6]  Brady T. West,et al.  Trends in Medical and Nonmedical Use of Prescription Opioids Among US Adolescents: 1976–2015 , 2017, Pediatrics.

[7]  B. Martin,et al.  Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use — United States, 2006–2015 , 2017, MMWR. Morbidity and mortality weekly report.

[8]  V. Menzies,et al.  Polypharmacy, Opioid Use, and Fibromyalgia , 2017, Biological research for nursing.

[9]  D. Sherry,et al.  Trends in Medicalization of Children with Amplified Musculoskeletal Pain Syndrome , 2016, Pain medicine.

[10]  J. Leventhal,et al.  National Trends in Hospitalizations for Opioid Poisonings Among Children and Adolescents, 1997 to 2012. , 2016, JAMA pediatrics.

[11]  J. Cappelleri,et al.  Evaluating Guideline‐recommended Pain Medication Use Among Patients with Newly Diagnosed Fibromyalgia , 2016, Pain practice : the official journal of World Institute of Pain.

[12]  L. Zemel,et al.  Juvenile Fibromyalgia: A Primary Pain, or Pain Processing, Disorder. , 2016, Seminars in pediatric neurology.

[13]  Roger Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. , 2016, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[14]  Yifei Liu,et al.  Treatment Patterns Associated with ACR-Recommended Medications in the Management of Fibromyalgia in the United States , 2016, Journal of managed care & specialty pharmacy.

[15]  "Weak" opioid analgesics. Codeine, dihydrocodeine and tramadol: no less risky than morphine. , 2016, Prescrire international.

[16]  S. Powers,et al.  Psychiatric Disorders in Young Adults Diagnosed with Juvenile Fibromyalgia in Adolescence , 2015, The Journal of Rheumatology.

[17]  D. Sherry,et al.  The Treatment of Juvenile Fibromyalgia with an Intensive Physical and Psychosocial Program. , 2015, The Journal of pediatrics.

[18]  S. Silverman,et al.  Identification of a potential fibromyalgia diagnosis using random forest modeling applied to electronic medical records , 2015, Journal of pain research.

[19]  D. Bush Emergency Department Visits for Adverse Reactions Involving the Pain Medication Tramadol , 2015 .

[20]  N. Schechter Pediatric pain management and opioids: the baby and the bathwater. , 2014, JAMA pediatrics.

[21]  D. Wallace,et al.  Amplified pain syndromes in children: treatment and new insights into disease pathogenesis , 2014, Current opinion in rheumatology.

[22]  M. Fesinmeyer,et al.  The economic costs of chronic pain among a cohort of treatment-seeking adolescents in the United States. , 2014, The journal of pain : official journal of the American Pain Society.

[23]  Chris Feudtner,et al.  Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation , 2014, BMC Pediatrics.

[24]  Tracy L. Skaer,et al.  Fibromyalgia: Disease Synopsis, Medication Cost Effectiveness and Economic Burden , 2014, PharmacoEconomics.

[25]  J. D. McLeod Juvenile fibromyalgia syndrome and improved recognition by pediatric primary care providers. , 2013, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.

[26]  K. Freedland,et al.  Prescription Opioid Analgesics Increase the Risk of Depression , 2014, Journal of General Internal Medicine.

[27]  S. Powers,et al.  Quality of Life and Emotional Functioning in Youth With Chronic Migraine and Juvenile Fibromyalgia , 2013, The Clinical journal of pain.

[28]  M. Grégoire,et al.  Drugs for chronic pain in children: a commentary on clinical practice and the absence of evidence. , 2013, Pain research & management.

[29]  P. McGrath,et al.  The epidemiology of chronic pain in children and adolescents revisited: A systematic review , 2011, PAIN.

[30]  M. Fitzcharles,et al.  Opioid use, misuse, and abuse in patients labeled as fibromyalgia. , 2011, The American journal of medicine.

[31]  T. Palermo,et al.  Patterns and predictors of health service utilization in adolescents with pain: comparison between a community and a clinical pain sample. , 2011, The journal of pain : official journal of the American Pain Society.

[32]  A. Palacio,et al.  Financial and clinical characteristics of fibromyalgia: a case-control comparison. , 2010, The American journal of managed care.

[33]  R. Dart,et al.  The underrecognized toll of prescription opioid abuse on young children. , 2009, Annals of emergency medicine.

[34]  S. Kashikar-Zuck,et al.  Social functioning and peer relationships of adolescents with juvenile fibromyalgia syndrome. , 2007, Arthritis and rheumatism.

[35]  C. Eccleston,et al.  The economic impact of chronic pain in adolescence: Methodological considerations and a preliminary costs-of-illness study , 2005, Pain.

[36]  M. Kosinski,et al.  Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. , 2005, Arthritis and rheumatism.

[37]  D. Binion,et al.  Polypharmacy and Crohn's disease , 2005, Alimentary pharmacology & therapeutics.

[38]  R. Bennett,et al.  Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. , 2003, The American journal of medicine.

[39]  A. Gray,et al.  The economic burden of back pain in the UK , 1999, Pain.

[40]  J. Bensing,et al.  Prevalence of chronic benign pain disorder among adults: a review of the literature , 1998, Pain.

[41]  R. Marcolongo,et al.  Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. , 1998, International journal of clinical pharmacology research.

[42]  Kevin Morgan,et al.  In the UK… , 1991 .